“Short agonist stop” protocol, an ovarian stimulation for poor responders in in vitro fertilization (IVF): A pilot study

IntroductionPoor responder patients remain a challenge in assisted reproductive technologies. The “short agonist stop” (SAS) stimulation protocol uses a double stimulation (flare up effect with the gonadotropin-releasing hormone (GnRH) agonist (GnRH-a) then gonadotropins) associated with a less stre...

Full description

Bibliographic Details
Published in:	Frontiers in Endocrinology
Main Authors:	Charlotte Mauries, Noemie Ranisavljevic, Caroline Mollevi, Cecile Brunet, Samir Hamamah, Sophie Brouillet, Tal Anahory
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Subjects:	ART IVF poor responders short agonist stop protocol POSEIDON criteria ovarian stimulation protocol
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2022.1056520/full

Similar Items

Follicular fluid biomarkers for prediction of human IVF outcome in women with poor ovarian response
by: Gerardo Barroso-Villa, et al.
Published: (2023-01-01)

Management Strategies for POSEIDON Group 2
by: Sesh Kamal Sunkara, et al.
Published: (2020-02-01)

Case Report: E2 luteal phase priming in a stop GnRH agonist combined with GnRH antagonist using a delta follitropin protocol in a poor responder: clinical case
by: Melissa María Morales Berrocal, et al.
Published: (2025-10-01)

The administration of GnRH and HCG: double trigger vs HCG alone for follicular oocyte maturation in poor IVF responders—a randomized controlled trial
by: Dalia Farouk, et al.
Published: (2024-11-01)

Long-term androgen priming by use of dehydroepiandrosterone (DHEA) improves IVF outcome in poor-responder patients. A randomized controlled study
by: Ashraf Moawad, et al.
Published: (2012-12-01)

The role of recombinant LH in ovarian stimulation: what’s new?
by: Carlo Alviggi, et al.
Published: (2025-03-01)

Luteal Phase Stimulation in the Same Cycle Is an Effective Strategy to Rescue POSEIDON Poor Responders with No Embryos after the First Follicular Stimulation
by: Abha Majumdar, et al.
Published: (2023-07-01)

Efficacy and safety of Shen Que (RN8) moxibustion on reproductive outcomes in unexpected poor ovarian responders: a randomized controlled trial
by: Jing-Yan Song, et al.
Published: (2024-08-01)

Ultra-Long GnRH Agonist Protocol During IVF/ICSI Improves Pregnancy Outcomes in Women With Adenomyosis: A Retrospective Cohort Study
by: Jie Lan, et al.
Published: (2021-05-01)

Growth Hormone and Reproduction: Lessons Learned From Animal Models and Clinical Trials
by: Carlos Dosouto, et al.
Published: (2019-06-01)

Management Strategies for POSEIDON's Group 1
by: Nikolaos P. Polyzos, et al.
Published: (2019-10-01)

The Benefits of Testosterone Therapy in Poor Ovarian Responders Undergoing In Vitro Fertilisation (IVF)
by: Petya Andreeva, et al.
Published: (2020-09-01)

An Observational Retrospective Cohort Trial on 4,828 IVF Cycles Evaluating Different Low Prognosis Patients Following the POSEIDON Criteria
by: Paolo Emanuele Levi-Setti, et al.
Published: (2019-05-01)

Clinical Effects of a Microdose GnRH Agonist Flare Regimen Administered to Poor Responders Undergoing ART Cycles
by: Robab Davar, et al.
Published: (2009-08-01)

Does the “delayed start” protocol with gonadotropin-releasing hormone antagonist improve the pregnancy outcome in Bologna poor responders? a randomized clinical trial
by: Mahnaz Ashrafi, et al.
Published: (2018-12-01)

Development and validation of a nomogram for failure to collect oocytes in POSEIDON Groups 3 and 4 undergoing IVF/ICSI treatment
by: Tian Ye, et al.
Published: (2024-12-01)

Evaluation of the Impact of Letrozole in Combination with the GnRH Antagonist Ovarian Stimulation Protocol in Patients Expected to Have a Poor Ovarian Response (POSEIDON Groups 3 and 4)
by: Bulut Varlı, et al.
Published: (2024-02-01)

Gonadotropin dose selection for repeat IVF cycles in POSEIDON Groups 1 and 2
by: Hao Wei, et al.
Published: (2025-07-01)

Is there any truth in the myth that IVF treatments involve weight gain?
by: Bozhena Saar-Ryss, et al.
Published: (2024-01-01)

Serum progesterone concentration on pregnancy test day might predict ongoing pregnancy after controlled ovarian stimulation and fresh embryo transfer
by: Marie Duport Percier, et al.
Published: (2023-06-01)

Individualized luteal phase support based on serum progesterone levels in frozen-thawed embryo transfer cycles maximizes reproductive outcomes in a cohort undergoing preimplantation genetic testing
by: Bertille du Boulet, et al.
Published: (2022-12-01)

Comparison between the modified long gonadotropin-releasing hormone agonist protocol and the non-downregulation protocol in POSEIDON groups: a propensity score matching retrospective cohort study
by: Chunyan Chen, et al.
Published: (2023-11-01)

Dehydroepiandrosterone Supplementation Improves the Outcomes of in vitro Fertilization Cycles in Older Patients With Diminished Ovarian Reserve
by: San-Nung Chen, et al.
Published: (2019-11-01)

Growth Hormone Supplementation May Not Improve Live Birth Rate in Poor Responders
by: Jinliang Zhu, et al.
Published: (2020-01-01)

Luteal Support with very Low Daily Dose of Human Chorionic Gonadotropin after Fresh Embryo Transfer as an Alternative to Cycle Segmentation for High Responders Patients Undergoing Gonadotropin-Releasing Hormone Agonist-Triggered IVF
by: Andrea Roberto Carosso, et al.
Published: (2021-03-01)

Effects of a Low-dose Leuprorelin Long Protocol on the Ovarian Response and Cycle Outcome in IVF
by: Yu-Chiao Yi, et al.
Published: (2004-06-01)

The Efficacy of Decreased Ovarian Reserve on in Vitro Fertilization Outcome
by: Özlem KARA, et al.
Published: (2023-12-01)

Young obese patients may benefit from GnRH-a long protocol contributing to higher implantation rate and live birth rate of fresh IVF-ET cycles
by: Qi Wan, et al.
Published: (2023-10-01)

Analysis of factors associated with IVF/ICSI clinical outcomes in advanced maternal age patients with normal ovarian reserve under the POSEIDON criteria
by: Yicen Meng, et al.
Published: (2025-10-01)

Rate of rebound in follicle growth after cessation of ovarian stimulation in initial non‐responders: a prospective cohort study
by: Norbert Gleicher, et al.
Published: (2021-01-01)

Cumulative live birth rates and birth outcomes after IVF/ICSI treatment cycles in young POSEIDON patients: A real-world study
by: Enqi Yan, et al.
Published: (2023-03-01)

Comparison of Controlled Ovarian Stimulation Protocols on IVF Outcome in Normal and Poor Responders
by: Deniz Esinler, et al.
Published: (2013-12-01)

Effect of basal luteinizing hormone/follicle-stimulating hormone ratio on clinical outcome of In Vitro fertilization in patients with polycystic ovarian syndrome: a retrospective cohort study
by: Dan Shan, et al.
Published: (2024-11-01)

Effectiveness of infertile women’s commitment to implement in vitro fertilization (long/short) protocols
by: Hawraa Hussein Ghafel, et al.
Published: (2016-04-01)

GnRH Antagonist/Letrozole Versus Microdose GnRH Agonist Flare Protocol in Poor Responders Undergoing In Vitro Fertilization
by: Robab Davar, et al.
Published: (2010-09-01)

Stubborn Exercise Responders–Where to Next?
by: Leo R. Bell, et al.
Published: (2022-06-01)

Maternal and neonatal complications after IVF/ICSI-fresh embryo transfer in low-prognosis women under the POSEIDON criteria: a retrospective cohort study
by: Shiguang Li, et al.
Published: (2023-12-01)

Increasing dominant follicular proportion was associated with adverse IVF/ICSI outcomes in low-prognosis women undergoing GnRH antagonist protocol: a retrospective cohort study
by: Qijun Xie, et al.
Published: (2024-08-01)

Double Stimulation in the Same Ovarian Cycle (DuoStim) to Maximize the Number of Oocytes Retrieved From Poor Prognosis Patients: A Multicenter Experience and SWOT Analysis
by: Alberto Vaiarelli, et al.
Published: (2018-06-01)

Soft versus Conventional Protocol in Ovarian Stimulation in Intracytoplasmic Sperm Injection Cycles for Poor Responders: A randomized clinical trial
by: Abd El-Naser Abd El-Gaber Ali, et al.
Published: (2022-01-01)